Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR2 | O15552 | 10/20 | 0.42 |
| ▸ | PRCP | P42785 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | PPARG | P37231 | 3/20 | 0.36 |
| ▸ | BRD4 | O60885 | 1/20 | 0.36 |
| ▸ | GRN | P28799 | 1/20 | 0.35 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1906571 | 0.92 | FFAR2 (0.47) | FFAR2PRCPPOLBPPARGBRD4 | |
| SCHEMBL1905489 | 0.92 | FFAR2 (0.47) | FFAR2PRCPPOLBPPARGBRD4 | |
| SCHEMBL9899646 | 0.92 | FFAR2 (0.47) | FFAR2PRCPPOLBPPARGBRD4 | |
| SCHEMBL22491784 | 0.92 | FFAR2 (0.47) | FFAR2PRCPPOLBPPARGBRD4 | |
| SCHEMBL14798252 | 0.82 | CYP2D6 (0.46) | FFAR2POLB | |
| SCHEMBL1932498 | 0.82 | CYP2D6 (0.46) | FFAR2POLB | |
| SCHEMBL1905993 | 0.80 | FFAR2 (0.47) | FFAR2PRCPBRD4 | |
| SCHEMBL1907199 | 0.80 | FFAR2 (0.47) | FFAR2PRCPBRD4 | |
| SCHEMBL24893827 | 0.79 | AKR1C3 (0.46) | PPARGGRNSORT1 | |
| SCHEMBL24893812 | 0.79 | AKR1C3 (0.46) | PPARGGRNSORT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3717480-A1 | METHOD FOR PRODUCING (3S)-3-(4-CHLOR-3-{[(2S,3R)-2-(4-CHLORPHENYL)-4,4,4-TRIFLUOR-3-METHYLBUTANOYL]AMINO}PHENYL)-3-CYCLO-PROPYLPROPANOIC ACID AND THE CRYSTALLINE FORM THEREOF FOR USE AS A PHARMACEUTICAL INGREDIENT | Bayer Pharma Aktiengesellschaft (DE) | 2020-10-07 | — | — | EP | disclosed |
| CN-111433204-A | Process for the preparation of (3S) -3- (4-chloro-3- { [ (2S,3R) -2- (4-chlorophenyl) -4,4, 4-trifluoro-3-methylbutyryl ] amino } phenyl) -3-cyclopropylpropionic acid and crystalline forms thereof for use as a pharmaceutically active substance | 拜耳制药股份公司 | 2020-07-17 | — | — | CN | disclosed |